A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
Intensive combined therapy including modification of the lifestyle, intake of metformin and/or sulfonylureas, insulin treatment in the absence ofadequate HbAc1 control, hypolipidemic, early antihypertensive and antithrombotic therapy not only decreases the frequency of DM2 complicationsbut also redu...
Enregistré dans:
Auteurs principaux: | Yury Shavkatovich Khalimov, Alla Vsevolodovna Rudakova |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/054ce88c5fff4e6dadc21c6fbb38b1e6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed?
par: Marina Vladimirovna Shestakova, et autres
Publié: (2015) -
Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
par: Alla Vsevolodovna Rudakova
Publié: (2011) -
Vildagliptin and its role in the treatment of diabetes mellitus
par: Yury Shavkatovich Khalimov
Publié: (2010) -
Review of the results of the EASYDia international observational study. The effect of dose titration of diabeton MR on the effectiveness of treatment of type 2 diabetes
par: Natalia Р. Trubitsyna, et autres
Publié: (2019) -
Barriers for efficacious hypoglycemic therapy in clinical practice (results of the Dialogue study)
par: Irina Evgen'evna Sapozhnikova, et autres
Publié: (2010)